Latest Conference Articles

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

PQA is also committed to national goals related to HIV and reducing HIV ending the epidemic.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

There are many initiatives that are going on at PQA right now that are related to health equity.

The goals of the pharmacy measures are ultimately to be used in value based arrangements.

There are other courses available on HIV, but PQA's surveys the 13 medication related quality measures out there for HIV.

The term "value" is used interchangeably across our healthcare system.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

PQA is working on developing measures specifically for evaluating pharmacy performance measurement.

Neil Lund, senior advisor, Avelere Health and Ryan Urgo, managing director, Health Policy, Avelere Health, discuss the impact of President Biden’s health care agenda on the pharmacy field.

Doug Long, vice president, Industry Relations, IQVIA, discusses notable trends reshaping specialty pharmaceutical channels and the impact of these developments on the role of the pharmacist in the health care team.

The SDOH resource guide focuses on services specific to the pharmacy and pharmacists.

The PQA team is diverse, and they have expertise in quantitative research as well as quality.

These measures are specified for application to pharmacies, as opposed to health plan measures.

Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.

Tracy Russell, senior director, State Government Affairs at CoverMyMeds, discusses state and federal legislation that may be impacting the future of specialty pharmacies and the patient care they deliver.

The growth of telehealth during the COVID-19 pandemic has caused health care providers to search for innovative solutions for harder to reach patient populations.

Even before the COVID-19 pandemic, vaccine hesitancy has been a challenge among adult patient populations.

Sneha Sharma, director, specialty clinical solutions at Magellan Health, discusses some trends in the rare disease space that she recommends pharmacists keep an eye on this year.

Pharmacists are well suited to help patients overcome the barriers that prevent access to therapy regimens.

It is essential to change the way pharmacists address the needs of diverse populations.

Amy Ware, director, specialty clinical solutions at Magellan Health, discusses what it means to be future focused as a pharmacist in the specialty pharmacy field.